Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1Phase 1 1

Status

Unknown 3Completed 2

Sponsor Class

NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Lymphoma 16Leukemia 14Breast Neoplasms 8Lymphoma, Non-Hodgkin 7Lymphoma, Mantle-Cell 7Lymphoma, Large-Cell, Immunoblastic 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myeloid, Acute 6Neoplasms, Plasma Cell 5Multiple Myeloma 5Leukemia, Lymphocytic, Chronic, B-Cell 5Burkitt Lymphoma 5Neuroblastoma 4Myelodysplastic Syndromes 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myelomonocytic, Acute 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Hodgkin Disease 4Congenital Abnormalities 4Recurrence 3Myeloproliferative Disorders 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoma, Large-Cell, Anaplastic 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3

Interventions

Cyclophosphamide 9Epirubicin 6Docetaxel 6Fluorouracil 4Bevacizumab 4Trastuzumab 3Tamoxifen 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Neoadjuvant Therapy 3Thiotepa 2Paclitaxel 2Filgrastim 2Carboplatin 2pembrolizumab 1aldesleukin 1Vinorelbine 1Therapeutics 1Methotrexate 1Mesna 1Hypnosis 1High-Energy Shock Waves 1Goserelin 1Early Intervention, Educational 1Doxorubicin 1Cisplatin 1Chemotherapy, Adjuvant 1Capecitabine 1CMF regimen 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Inflammatory Breast Neoplasms × Peripheral Blood Stem Cell Transplantation × Clear all
NCT00002627 2014-01-10

Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer

National Cancer Institute (NCI)

Phase 1/2 Unknown
30 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00003680 2013-11-06

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
300 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00002616 2013-09-20

Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
36 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡